Citi Pharma Shareholders Approve Memorandum Change for Cannabis and Hemp Business
Citi Pharma shareholders have approved an amendment to the company’s Memorandum of Association, allowing it to undertake cannabis, industrial hemp and medicinal cannabis activities subject to regulatory approvals.
Citi Pharma Board Approves Demerger Scheme to Vest Real Estate Assets into Wholly Owned SPV for REIT
Citi Pharma Limited (PSX: CPHL) has announced a Board-approved Scheme of Arrangement and Demerger to transfer two prime Lahore properties into a wholly-owned SPV.